bioLOGIC 2000
	ECPI , Noga Hilton Hotel, Geneva 7-9 June 2000
	Delivering Integrated Scale-up and Manufacturing Solutions Day 1 - 7 June 2000 - Pre Conference Briefing Day 2 - 8 June 2000 - Striving for seamless and integrated biologic process scale-up Day 3 - 9th June 2000 - Driving towards quality, efficiency and consistency of scale-up and manufacturing through leading edge. Please visit the website at www.ecpi-online.com for full details.
	Organized by:	ECPI
	Invited Speakers:	David Chalmers, European Project Manager, Warner Lambert, UK Paul Edwards, Chairman of Manufacturing, Bio Industry Association, UK Ian Gibson, MP, Chair of Parliamentary Office of Science & Technology, House of Commons, UK Roger-Marc Nicoud, President & CEO, Novasep, France Val Kurkonis, President, Phasex Corporation, USA Dr Markus Burri, Pharmaceutical Industry Group, PricewaterhouseCoopers, Switzerland Dr Peter Everett, Head of Biopharmaceutical Sciences, Glaxo Wellcome, UK Amy Murnane, Smithkline Beecham, USA David Chalmers, European Project Manager, Warner Lambert, UK Dr Mak Jawadekar, Manager Pharmaceutical R&D, Pfizer, USA Dr Douglas Seifert, Director, Biologics Pilot Plant, Merck & Co, USA Dr Jill Myers, Section Head, Process Biochemistry, Biogen Inc, USA Dr Michel Thiry, Biopharmaceutical Business Unit Manager, Eurogentec SA, Belgium Inger Mollerup, Department Leader in Protein, Novo Nordisk A/S, Denmark Anne Marie Georges, Associate Diector Legal, Regulatory & Technical Matters, Smithkline Beecham Biologicals, Belgium Dr Steve Chatfield, Development Director, Microscience, UK Andrew Russell, Director of BioProcess Research & Development, Eli Lilly & Co, USA Robert Whalen, Senior Research Fellow, Maxygen Inc, Redwood City, CA USA Dr Kurt Konopitzky, Head of Division Production & Technology/Biopharmaceuticals, Boehringer Ingelheim GmbH, Austria Stephen Drew, BioProcess, Merck, USA Rich Rakow, Vice President of Global Contract Manufacturing, Pharmacia & Upjohn, USA Jack Regan, Director of Manufacturing, Genentech Inc, USA Frank Ollington, Senior Vice President of Operations, Genzyme Inc, USA Ronald J Meyer, Strategic Project Planner, Formerley Eli Lilly & Co, Usa
	Deadline for Abstracts:	n/a
	Registration:	Registration for all 3 days at the Early Bird Rate: £,1295 Normal 3 day Conference Rate: £1,495 2 Day Conference: £995 1 Day Briefing: £695
	Email for Requests and Registration:	ecpi@aic-uk.com
	Posted by: Tracy Moring   Host: no-dns-yet.aic-gb.com date: March 09, 2000 16:01:28 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.